Emmanuel Hui
Emmanuel Andrew HUI is a Co-founder of Moogene, a gene therapy company listed on the Korean stock exchange (322970.KS). He also manages a cancer diagnostic startup, Angene Biotechnology, backed by the Hong Kong Government Innovation and Technology Commission (ITC).
HUI is an investor at Sagamore Investments / Impact Asia, a private equity firm with exposure to over 2,000 companies.[1]. He manages Pentepebble, a Greater Bay Area life sciences investment initiative[2]. He is also a Board Member of the Hong Kong Children's Hospital Research Ethics Committee.
HUI graduated from Dartmouth as a Senior Fellow (Chemistry) and has published multiple peer-reviewed scientific journals[3].
Publications
- Ryu, J.Y., Won, E.J., Lee, H.A.R., Kim, J.H., Hui, E., Kim, H.P. and Yoon, T.J., 2020. Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy. Biomaterials, 232, p.119736.
- Ha, S.W., Cho, H.S., Yoon, Y.I., Jang, M.S., Hong, K.S., Hui, E., Lee, J.H. and Yoon, T.J., 2017. Ions doped melanin nanoparticle as a multiple imaging agent. Journal of nanobiotechnology, 15(1), pp.1-9.
- Ryu, J.Y., Choi, Y.J., Won, E.J., Hui, E., Kim, H.S., Cho, Y.S. and Yoon, T.J., 2020. Gene editing particle system as a therapeutic approach for drug-resistant colorectal cancer. Nano Research, 13(6), pp.1576-1585.
- Hui, S.S.C., Kwok, R.C.W., Chan, J.K.W. and Hui, E.A., 2013, May. The Virtual Trainer: Facilitating Physical Activity and Fitness Improvement Through Internet and Mobile Phones. In MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (Vol. 45, No. 5, pp. 388-388). 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA: LIPPINCOTT WILLIAMS & WILKINS.
Interviews
- Life Sciences Review - Hong Kong's Young 'Baron of Biotech': Looks For Friends[4]
- The Chinese University of Hong Kong Pre-Incubation Center - Investor’s Viewpoint: How Can Start-up Founders Equip Themselves?[5]
- Hong Kong Trade Development Council (HKTDC) - Healthtech fund focuses on GBA : An entrepreneur views the Greater Bay Area as an ideal medical technology innovation hub.[6]
References
- ↑ "Sagamore - Home Page". sagainv.com. Retrieved 2022-01-04.
- ↑ "Pentepebble | Life Sciences | Venture Capital | Greater Bay Area | Hong Kong". Pentepebble. Retrieved 2022-01-04.
- ↑ "Emmanuel Hui". scholar.google.com. Retrieved 2022-01-04.
- ↑ Li, Cheng (2021-02-10), "Economic Radiating Effects of the Guangdong–Hong Kong–Macao Greater Bay Area in China Effects of the Guangdong–Hong Kong–Macao Greater Bay Area", Guangdong-Hong Kong-Macao Greater Bay Area, WORLD SCIENTIFIC, pp. 205–259, retrieved 2022-01-04
- ↑ "Investor's Viewpoint: How Can Start-up Founders Equip Themselves?". CUHK Business School. Retrieved 2022-01-04.
- ↑ "Healthtech fund focuses on GBA". Hong Kong Means Business. Retrieved 2022-05-12.
This article "Emmanuel Hui" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Emmanuel Hui. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
